Literature DB >> 23255114

Stacking the DEK: from chromatin topology to cancer stem cells.

Lisa M Privette Vinnedge1, Ferdinand Kappes, Nicolas Nassar, Susanne I Wells.   

Abstract

Stem cells are essential for development and tissue maintenance and display molecular markers and functions distinct from those of differentiated cell types in a given tissue. Malignant cells that exhibit stem cell-like activities have been detected in many types of cancers and have been implicated in cancer recurrence and drug resistance. Normal stem cells and cancer stem cells have striking commonalities, including shared cell surface markers and signal transduction pathways responsible for regulating quiescence vs. proliferation, self-renewal, pluripotency and differentiation. As the search continues for markers that distinguish between stem cells, progenitor cells and cancer stem cells, growing evidence suggests that a unique chromatin-associated protein called DEK may confer stem cell-like qualities. Here, we briefly describe current knowledge regarding stem and progenitor cells. We then focus on new findings that implicate DEK as a regulator of stem and progenitor cell qualities, potentially through its unusual functions in the regulation of local or global chromatin organization.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23255114      PMCID: PMC3570517          DOI: 10.4161/cc.23121

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  160 in total

1.  Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation.

Authors:  Atsushi Asakura; Michael A Rudnicki
Journal:  Exp Hematol       Date:  2002-11       Impact factor: 3.084

2.  Intron removal requires proofreading of U2AF/3' splice site recognition by DEK.

Authors:  Luis Miguel Mendes Soares; Katia Zanier; Cameron Mackereth; Michael Sattler; Juan Valcárcel
Journal:  Science       Date:  2006-06-30       Impact factor: 47.728

Review 3.  Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.

Authors:  Donald G Phinney; Darwin J Prockop
Journal:  Stem Cells       Date:  2007-09-27       Impact factor: 6.277

4.  Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.

Authors:  Jessica Tatarek; Kathleen Cullion; Todd Ashworth; Rachel Gerstein; Jon C Aster; Michelle A Kelliher
Journal:  Blood       Date:  2011-06-13       Impact factor: 22.113

Review 5.  Tissue stem cells: new tools and functional diversity.

Authors:  Markus Grompe
Journal:  Cell Stem Cell       Date:  2012-06-14       Impact factor: 24.633

6.  Expression and isotopic labeling of structural domains of the human protein DEK.

Authors:  Matthew Devany; N Prasad Kotharu; Hiroshi Matsuo
Journal:  Protein Expr Purif       Date:  2005-04       Impact factor: 1.650

7.  Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity.

Authors:  R W Storms; A P Trujillo; J B Springer; L Shah; O M Colvin; S M Ludeman; C Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

Review 8.  Crosstalk of Notch with p53 and p63 in cancer growth control.

Authors:  G Paolo Dotto
Journal:  Nat Rev Cancer       Date:  2009-07-16       Impact factor: 60.716

9.  Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.

Authors:  Arnout G Schepers; Hugo J Snippert; Daniel E Stange; Maaike van den Born; Johan H van Es; Marc van de Wetering; Hans Clevers
Journal:  Science       Date:  2012-08-01       Impact factor: 47.728

10.  Human Ku70/80 interacts directly with hTR, the RNA component of human telomerase.

Authors:  Nicholas S Y Ting; Yaping Yu; Brant Pohorelic; Susan P Lees-Miller; Tara L Beattie
Journal:  Nucleic Acids Res       Date:  2005-04-11       Impact factor: 16.971

View more
  28 in total

1.  The nuclear DEK interactome supports multi-functionality.

Authors:  Eric A Smith; Eric F Krumpelbeck; Anil G Jegga; Malte Prell; Marie M Matrka; Ferdinand Kappes; Kenneth D Greis; Abdullah M Ali; Amom R Meetei; Susanne I Wells
Journal:  Proteins       Date:  2017-11-11

2.  DEK over-expression promotes mitotic defects and micronucleus formation.

Authors:  Marie C Matrka; Robert F Hennigan; Ferdinand Kappes; Monica L DeLay; Paul F Lambert; Bruce J Aronow; Susanne I Wells
Journal:  Cell Cycle       Date:  2015-05-06       Impact factor: 4.534

3.  Loss of DEK induces radioresistance of murine restricted hematopoietic progenitors.

Authors:  Juana Serrano-Lopez; Kalpana Nattamai; Nicholas A Pease; Miranda S Shephard; Ashley M Wellendorf; Mathieu Sertorio; Eric A Smith; Hartmut Geiger; Susanne I Wells; Jose A Cancelas; Lisa M Privette Vinnedge
Journal:  Exp Hematol       Date:  2017-12-27       Impact factor: 3.084

4.  Systematically defining single-gene determinants of response to neoadjuvant chemotherapy reveals specific biomarkers.

Authors:  Agnieszka K Witkiewicz; Uthra Balaji; Erik S Knudsen
Journal:  Clin Cancer Res       Date:  2014-07-21       Impact factor: 12.531

5.  Prostate cancer. Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer.

Authors:  Jean-Philippe P Theurillat; Namrata D Udeshi; Wesley J Errington; Tanya Svinkina; Sylvan C Baca; Marius Pop; Peter J Wild; Mirjam Blattner; Anna C Groner; Mark A Rubin; Holger Moch; Gilbert G Prive; Steven A Carr; Levi A Garraway
Journal:  Science       Date:  2014-10-02       Impact factor: 47.728

6.  A DEK domain-containing protein modulates chromatin structure and function in Arabidopsis.

Authors:  Sascha Waidmann; Branislav Kusenda; Juliane Mayerhofer; Karl Mechtler; Claudia Jonak
Journal:  Plant Cell       Date:  2014-11-11       Impact factor: 11.277

Review 7.  The genomic landscape of retinoblastoma: a review.

Authors:  Brigitte L Thériault; Helen Dimaras; Brenda L Gallie; Timothy W Corson
Journal:  Clin Exp Ophthalmol       Date:  2013-05-22       Impact factor: 4.207

8.  The DEK Oncoprotein Is a Critical Component of the EKLF/KLF1 Enhancer in Erythroid Cells.

Authors:  Felix Lohmann; Mohan Dangeti; Shefali Soni; Xiaoyong Chen; Antanas Planutis; Margaret H Baron; Kyunghee Choi; James J Bieker
Journal:  Mol Cell Biol       Date:  2015-08-24       Impact factor: 4.272

9.  DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.

Authors:  Lijuan Lin; Junjie Piao; Wenbin Gao; Yingshi Piao; Guang Jin; Yue Ma; Jinzi Li; Zhenhua Lin
Journal:  BMC Cancer       Date:  2013-07-31       Impact factor: 4.430

10.  The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation.

Authors:  Carl Sandén; Linnea Järvstråt; Andreas Lennartsson; Per Ludvik Brattås; Björn Nilsson; Urban Gullberg
Journal:  Mol Cancer       Date:  2014-09-12       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.